BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28592463)

  • 1. Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus.
    Rhee JJ; Zheng Y; Montez-Rath ME; Chang TI; Winkelmayer WC
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28592463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).
    Laiteerapong N; Ham SA; Gao Y; Moffet HH; Liu JY; Huang ES; Karter AJ
    Diabetes Care; 2019 Mar; 42(3):416-426. PubMed ID: 30104301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target.
    Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Svensson AM; Eliasson B; Nicolucci A
    Cardiovasc Diabetol; 2022 Jan; 21(1):13. PubMed ID: 35073913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CR; Leite NC; Ferreira MT; Salles GF
    Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
    J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.
    Hoshino J; Hamano T; Abe M; Hasegawa T; Wada A; Ubara Y; Takaichi K; Inaba M; Nakai S; Masakane I;
    Nephrol Dial Transplant; 2018 Jul; 33(7):1150-1158. PubMed ID: 29528439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.
    Raghavan S; Vassy JL; Ho YL; Song RJ; Gagnon DR; Cho K; Wilson PWF; Phillips LS
    J Am Heart Assoc; 2019 Feb; 8(4):e011295. PubMed ID: 30776949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor glycemic control is a significant predictor of cardiovascular events in chronic hemodialysis patients with diabetes.
    Tsujimoto Y; Ishimura E; Tahara H; Kakiya R; Koyama H; Emoto M; Shoji T; Inaba M; Kishimoto H; Tabata T; Nishizawa Y
    Ther Apher Dial; 2009 Aug; 13(4):358-65. PubMed ID: 19695075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery disease severity modifies associations between glycemic control and both mortality and myocardial infarction.
    Raghavan S; Liu WG; Michael Ho P; Plomondon ME; Barón AE; Caplan L; Joynt Maddox KE; Magid D; Saxon DR; Voils CI; Bradley SM; Maddox TM
    J Diabetes Complications; 2018 May; 32(5):480-487. PubMed ID: 29483016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.
    Östgren CJ; Sundström J; Svennblad B; Lohm L; Nilsson PM; Johansson G
    Diabet Med; 2013 May; 30(5):e170-7. PubMed ID: 23350893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Long-term HbA
    Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
    Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visit-to-Visit HbA
    Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
    Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes.
    Triebswetter S; Gutjahr-Lengsfeld LJ; Schmidt KR; Drechsler C; Wanner C; Krane V
    Am J Nephrol; 2018; 47(1):30-39. PubMed ID: 29320770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.
    Xu L; Chan WM; Hui YF; Lam TH
    Diabet Med; 2012 Mar; 29(3):393-8. PubMed ID: 21916977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic control and cardiovascular events in diabetic hemodialysis patients.
    Drechsler C; Krane V; Ritz E; März W; Wanner C
    Circulation; 2009 Dec; 120(24):2421-8. PubMed ID: 19948978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HbA1c and survival in maintenance hemodialysis patients with diabetes in Han Chinese population.
    Li X; Xu X; Liu J; Yang J; Fang L; Miao L; Di J; He X
    Int Urol Nephrol; 2014 Nov; 46(11):2207-14. PubMed ID: 24966096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy.
    Jin YP; Su XF; Yin GP; Xu XH; Lou JZ; Chen JJ; Zhou Y; Lan J; Jiang B; Li Z; Lee KO; Ye L; Ma JH
    J Diabetes Complications; 2015 Apr; 29(3):395-9. PubMed ID: 25681043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study.
    Fangel MV; Nielsen PB; Kristensen JK; Larsen TB; Overvad TF; Lip GYH; Jensen MB
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007030. PubMed ID: 30995869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of glycated hemoglobin A
    Sinning C; Makarova N; Völzke H; Schnabel RB; Ojeda F; Dörr M; Felix SB; Koenig W; Peters A; Rathmann W; Schöttker B; Brenner H; Veronesi G; Cesana G; Brambilla P; Palosaari T; Kuulasmaa K; Njølstad I; Mathiesen EB; Wilsgaard T; Blankenberg S; Söderberg S; Ferrario MM; Thorand B
    Cardiovasc Diabetol; 2021 Nov; 20(1):223. PubMed ID: 34781939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.